Thyroid dysfunctions induced by tyrosine kinase inhibitors

Author： Fallahi Poupak   Ferrari Silvia M   Vita Roberto   Di Domenicantonio Andrea   Corrado Alda   Benvenga Salvatore   Antonelli Alessandro  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.6, 2014-06, pp. : 723-733

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selective tyrosine kinase inhibitors

By Wilkinson S.E.   Harris W.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. : 462-483

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular toxicity of tyrosine kinase inhibitors

By Mouhayar Elie   Durand Jean-Bernard   Cortes Jorge  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 687-696

Informa Healthcare

Access to resources Recommend Favorite

The potentiating effect of genistein on the relaxation induced by isoproterenol in rat aortic rings - Suppression by tyrosine kinase inhibitors

By Satake N.   Shibata S.  

General Pharmacology, Vol. 33, Iss. 3, 1999-09 ,pp. : 221-227

Elsevier

Access to resources Recommend Favorite

Tyrosine kinase inhibitors regulate serotonin uptake in platelets

By Helmeste D.M.   Siu Wa T.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite